JanOne to Present In Person and by Video at H.C. Wainwright’s 25th Annual Global Investment Conference

Posted on by

Chief Medical Officer Dr. Amol Soin will discuss innovative approaches to pain management and JanOne’s development of non-addicting treatments for pain LAS VEGAS, Aug. 31, 2023 /PRNewswire/ — JanOne (Nasdaq: JAN), the biopharmaceutical company focused on developing non-addicting…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.